|
BACKGROUND Health care administrators, policy makers, and practitioners must balance the needs and desires of individual patients with the needs and desires of society at large, realizing that not all needs and desires can be met. Information comparing the expected gains of a medical intervention against the expected cost of that intervention versus other health care interventions is often difficult to interpret or compare. ISPOR’s role as a scientific society is to assist in the development and dissemination of scientific policy (good practices in health outcomes research and its use in decision-making), to inform its membership of relevant public policy developments and when appropriate, to seek to influence public policy-making on the basis of good scientific practice in order to improve the use of scientific information (i.e. pharmacoeconomic information) in decision-making. ISPOR makes a distinction between public policy (legal framework governing the provision of health care in a particular jurisdiction) and scientific policy (good practice in health outcomes research and its use in decision making). ISPOR’s primary focus is on scientific policy issues. To assure that ISPOR is addressing key research and policy issues in pharmacoeconomics and outcomes research, the ISPOR Health Science Policy Council, an advisory council to the Board of Directors, was established May 2004. The mission of the Health Science Policy Council is to advise the Society on key science research and research policy issues in pharmacoeconomics and outcomes research. MEMBERSHIP The ISPOR Health Science Policy Council is composed of past ISPOR Presidents, recipients of the Avedis Donabedian Lifetime Achievement Award and key thought leaders selected by the Council. Council membership shall not exceed 25 members. An ISPOR Past President becomes a member on the first day they assume the role as ISPOR Past President (July 1). Each year the Council also invites the recipient of the ISPOR Avedis Donebedian Outcomes Research Lifetime Achievement Award to be a Council member. The recipient has the option to decline. To assure the Council reflects the interest of the ISPOR membership with presentations at the ISPOR annual meetings/congresses as a barometer of that interest, the Council and the Board of Directors can invite key thought leaders from areas that are under-represented on the Council. (e.g. patient-reported outcomes, preference/utility assessments, health care policy analysis and use of “real world” data, health care decision makers, etc.). The Council can invite outcomes research experts to serve on an ad-hoc, as-needed basis. If an issue arises in which the Council does not have an expert, the Council can agree to invite an individual that may have a specific expertise to serve on the Council, but not as a member, for the development of the issue. If an ISPOR member is interested in being considered as a member of the Health Science Policy Council, he/she can submit a letter of interest to the Board of Directors for consideration. Council members identify and discuss issues submitted by ISPOR members and Council members at bi-monthly meetings. Issues approved by the Council are then presented to the Board of Directors for discussion and further action. COUNCIL ACTIVITIES Issues Currently Under Consideration
Issues Approved by Board as ISPOR Task Forces
Annual Leadership Reports |
|
Contact ISPOR @
info@ispor.org
| View Legal Disclaimer |